This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe
November 3–5, 2025
Vienna Congress and Convention Center, Vienna, AustriaNovember 11–12, 2025 | Digital Partnering

Junsang Yoo
CEO at Stand Up Therapeutics Inc.
Speaker

Profile

Education
- 2006.08 - 2011.05
B.S in Biochemistry Virginia Tech., Blacksburg, USA
- 2013.08 - 2019.06
Ph.D. and Post Doc in Biomedical engineering, Dongguk University, S. Korea

Professional Experience
- 2019.06 - 2020.08
Invited Researcher Neurodegenerative disease researcher of KIST Center for Neuroscience
- 2021.01 - present
Chief Scientist and CEO in Standup Therapeutics.
- 2023 - present
Frontier Publishing Group publishing editor

Research Interests
Gene Therapy, Cell fate conversion, Cell resetting technology, Epigenetics

Honors & Awards (Maximum 3)
2016
Nominated promising young-scientist researcher in Korea Society for Stem Cell Research (KSSCR)
2018
International Conference Korean society for molecular and cellular biology (KSMCB)
TAKARA best research award
2018
Best research article award in KSMCB

Publications (Maximum 3)
- Yoo J*, Electromagnetized gold nanoparticles mediate direct lineage reprogramming into induced dopamine neurons in vivo for Parkinson's disease therapy. Nature Nanotechnology. 2017 Oct;12(10):1006-1014. (IF:43.341)
- Lee S, Yoo J**, Plasmonic Annular Nanotrenches with 1 nm Nanogaps for Detection of SARS-CoV-2 Using SERS-Based Immunoassay. Nano Lett. 2024 Apr (IF: 10.8)
- Lee S, Yoo J** Elongated nanoporous Au networks improve somatic cell direct conversion into induced dopaminergic neurons for Parkinson's disease therapy. Acta biomaterialia. 2022 Aug (IF:10.633)